Kline Confirms that Excipients are on the Rise in a New Era for Biologics and Topicals

Biologics:

The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading

Oral Solids Continue to Dominate the Excipients Market

Oral Solids Continue to Dominate the Excipients Market, While the Parenteral Route Accelerates Growth

By definition, excipients are inactive substances that serve as a medium or vehicle for pharmaceutical active drug substances. Over the years, excipients have been increasingly developed to provide important functionalities to pharmaceutical formulations. The global pharmaceutical market is worth more than USD 1.1 trillion as of 2017 and expected to grow more than 4% annually over the next five years. The global market of specialty excipients in the overall pharmaceutical industry is estimated at about USD 6.8 billion in 2017.Continue reading